Literature DB >> 7734269

Extradural ropivacaine and bupivacaine in hip surgery.

A P Wolff1, L Hasselström, H E Kerkkamp, M J Gielen.   

Abstract

We studied 126 patients undergoing elective hip surgery; they received 20 ml of 0.5%, 0.75%, 1.0% ropivacaine or 0.5% bupivacaine extradurally in a double-blind design. Sensory block (pinprick), motor block (modified Bromage scale), quality of analgesia and neuromuscular block were assessed intermittently. Heart rate and arterial pressure were measured at regular intervals. A total of 115 patients were evaluated for efficacy. Onset of analgesia, onset of motor block and maximum cephalad spread (T4) did not differ between the groups. Duration and quality of analgesia and motor block increased with the concentration of ropivacaine. Ropivacaine 1.0% provided a longer duration of analgesia and motor block, more intense motor block and more patients with satisfactory analgesia than 0.5% bupivacaine. More patients treated with the higher concentrations of ropivacaine required treatment for hypotension and bradycardia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7734269     DOI: 10.1093/bja/74.4.458

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  9 in total

Review 1.  Ropivacaine: a review of its use in regional anaesthesia and acute pain management.

Authors:  Dene Simpson; Monique P Curran; Vicki Oldfield; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Anaesthesia in the elderly. Special considerations.

Authors:  A G Jones; J M Hunter
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

3.  A double-blind comparison of ropivacaine 0.5%, 0.75%, 1.0% and bupivacaine 0.5%, injected epidurally, in patients undergoing abdominal hysterectomy.

Authors:  B T Finucane; A N Sandler; J McKenna; D Reid; A L Milner; M Friedlander; D Muzyka; S O'Callaghan-Enright; V Chan
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

Review 4.  Adverse effects and drug interactions associated with local and regional anaesthesia.

Authors:  M Naguib; M M Magboul; A H Samarkandi; M Attia
Journal:  Drug Saf       Date:  1998-04       Impact factor: 5.606

Review 5.  Benefit-risk assessment of ropivacaine in the management of postoperative pain.

Authors:  Wolfgang Zink; Bernhard M Graf
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

6.  Ropivacaine compared to lidocaine for tonsillectomy under local anaesthesia.

Authors:  Kostas Apostolopoulos; Ekaterini Labropoulou; Ragheed Samaan; Konstantinos Bogris
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-03-12       Impact factor: 2.503

7.  The intra-articular use of ropivacaine for the control of post knee arthroscopy pain.

Authors:  Efthimios P Samoladas; Byron Chalidis; Hlias Fotiadis; Ioanis Terzidis; Thomas Ntobas; Miltos Koimtzis
Journal:  J Orthop Surg Res       Date:  2006-12-23       Impact factor: 2.359

8.  Comparison of Postoperative Pain After Epidural Anesthesia Using 0.5%, 0.75% Ropivacaine and 0.5% Bupivacaine in Patients Undergoing Lower Limb Surgery: A Double-Blind Study.

Authors:  Tripat Kaur Bindra; Rajvinder Singh; Ruchi Gupta
Journal:  Anesth Essays Res       Date:  2017 Jan-Mar

9.  Analgesic efficacy and safety of epidural oxycodone in patients undergoing total hip arthroplasty: a pilot study.

Authors:  Bogumił Olczak; Grzegorz Kowalski; Wojciech Leppert; Agnieszka Bienert; Artur Teżyk; Michał Adamski; Stanisław Rzymski; Katarzyna Wieczorowska-Tobis
Journal:  J Pain Res       Date:  2017-09-27       Impact factor: 3.133

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.